The Challenge

A pharmaceutical manufacturer had to complete a full annual GMP audit cycle across 11 departments but didn’t have the internal capacity to execute it on time and to standard.

The Result

100% of audit objectives achieved across all 11 departments, delivered on time and fully aligned with EU GMP Part I, with zero compliance gaps and immediate CAPA-ready reporting.

Their team was flexible and responsive to our priorities. They adapted the audit focus to our key risk areas without compromising the integrity or compliance of the overall program.

Quality Director, Pharmaceutical Manufacturer

About the Case Study

Project Summary

A pharmaceutical manufacturer of finished medicinal products faced a critical compliance gap: their annual EU GMP internal audit cycle needed to cover 11 GMP-relevant departments but internal auditor capacity was insufficient to meet the required timeline.

The challenge wasn’t just completing the audits. It was doing so with consistent methodology, regulatory rigor, and zero delays on report delivery.

Key Challenges

1. Timeline and Coordination Across 11 Departments

Managing audit scheduling, execution, and timely report delivery across 11 GMP-relevant departments within a fixed annual window without disrupting day-to-day operations.

2. Consistency of GMP Audit Methodology

Maintaining uniform interpretation of EU GMP requirements across multiple auditors while adapting the audit focus to the client’s identified risk priorities.

3. GMP Manufacturing Area Compliance

Reviewing the manufacturing area design to verify full alignment with EU GMP requirements applicable to APIs.

Our Approach to GMP Internal Audit Execution

A structured, four-phase methodology aligned with EU GMP Part I:

Phase 1 – Planning & Scheduling: Coordination of audit dates aligned with the predefined annual program and departmental availability. Auditor assignment based on expertise and risk profile.
Phase 2 – Risk Alignment: Pre-audit alignment with each department to confirm risk areas and define targeted audit focus points — ensuring each audit added operational value, not just compliance checkboxes.
Phase 3 – Audit Execution: Structured execution following a methodology fully aligned with EU GMP Part I, ensuring consistent standards across all 11 departments.
Phase 4 – Reporting: Systematic classification of observations with timely delivery of audit reports, directly supporting CAPA initiation and continuous improvement cycles.

Results and Quantifiable Gains

100% of audit objectives achieved. Full program completed with consistent GMP standards across all departments.

Full audit program delivered on time. Internal resource burden reduced by leveraging qualified external auditors.

CAPA-ready findings aligned with quality and business objectives, enabling continuous improvement beyond baseline compliance.

Why Outsource GMP Internal Audit Execution?

Pharmaceutical manufacturers often face a structural challenge: GMP regulations require annual internal audits, but maintaining a fully qualified internal audit team year-round is resource-intensive.

Outsourcing GMP internal audit execution to a specialized provider delivers: